Our Partners
What our partners say...
...meticulous oversight, and unwavering commitment to participant safety consistently elevated the quality and pace of our trials...
Dr Juan Trujillo
Principal Investigator
Paediatrics/Paediatric Allergy
Cork University Hospital
The CRF’s support has made our participation in multinational trials, observational studies, and registries possible.
Prof. Michelle Murphy
Consultant Dermatologist
South Infirmary-Victoria University Hospital
...The CRF-UCC provides an enabling environment that allows clinical studies to be conducted efficiently, safely, and to the highest scientific standards...
Prof. Michael Clarkson
Consultant Nephrologist
Cork University Hospital
It’s a big milestone achieved considering the challenges and difficulties in the patient population.
Fortrea & AstraZeneca
Find Out MoreCRF-UCC were the highest recruiter in Ireland to a large multi-national study ... investigating a new therapy in bronchiectasis
Boehringer Ingelheim
Find Out MoreCRF-UCC recruited the first patient in Ireland onto the UNEEG medical device study, marking a significant advancement in epilepsy treatment.
UNEEG
Find Out MoreDr Juan Trujillo
"As Principal Investigator for the Peadiatric allergy immunotherapy clinical trials in Cork university hospital, I have had an exceptional experience collaborating with the Clinical Research Facility University College Cork (CRF-UCC). Their operational excellence, meticulous oversight, and unwavering commitment to participant safety consistently elevated the quality and pace of our trials. With their partnership, our site became the top recruiter in Europe, reflecting their efficiency in start-up, patient engagement, and data integrity. The CRF-UCC’s highly skilled team streamlined complex processes, anticipated challenges, and provided proactive, solutions-focused support at every stage. This level of professionalism with the strength of dedicated paediatric allergy research nurses directly contributed to impactful scientific outputs, including our co-authorship in the New England Journal of Medicine and further publications in leading allergy journals. Beyond performance metrics, the CRF-UCC fostered a culture of collaboration, transparency, and continuous improvement that empowered our investigators and coordinators to excel. I would enthusiastically recommend the CRF-UCC as a world-class partner for high-impact clinical research that has made me a better researcher. I’m profoundly proud of be part of this institution."
Prof. Michelle Murphy
"Working with the Clinical Research Facility has enabled our dermatology service to deliver real patient impact—providing early access to effective new drug treatments that have significantly improved disease control and quality of life for patients with severe skin disease. The CRF’s support has made our participation in multinational trials, observational studies, and registries possible."
Prof. Michael Clarkson
"As a Principal Investigator, my experience working with the CRF-UCC has been consistently excellent, both in terms of research outcomes and the quality of collaboration. The CRF-UCC provides an enabling environment that allows clinical studies to be conducted efficiently, safely, and to the highest scientific standards.
The infrastructure and support available through the CRF-UCC have had a tangible impact on the success of our clinical research programme in nephrology. Access to dedicated clinical space, skilled research nurses, and experienced operational staff has significantly streamlined study delivery, from participant recruitment through to data collection and follow-up. This level of coordinated support has not only improved timelines but has also enhanced data quality and protocol adherence.
Importantly, the expertise of the CRF-UCC team extends far beyond logistics. Their proactive approach, attention to detail, and their ability to anticipate challenges and implement effective solutions has been instrumental in achieving excellent research outcomes.
The research enabled by the CRF-UCC has contributed to meaningful advances in our field, including high-quality clinical trial activity, publications, successful grant applications, and, most importantly, improvements in patient care and clinical practice. The CRF-UCC fosters a culture of excellence, collaboration, and innovation, which is evident in their day to day activities.
Working with the CRF team is a genuinely positive experience. They are friendly, responsive, professional, and committed to supporting investigators and participants alike. Their collaborative ethos creates a strong sense of partnership, making them an invaluable component of our clinical research programme."
Fortrea & AstraZeneca
"On behalf of Fortrea and AstraZeneca, I would like to extend gratitude for your work and congratulations to your team on randomising your first patient at site and the first BRISOTE patient in Ireland. It’s a big milestone achieved considering the challenges and difficulties in the patient population."
Boehringer Ingelheim
“April 2026, CRF-UCC recruited the 1st Cystic Fibrosis patient in Ireland, and were the highest recruiter in Ireland to a large multi-national study, funded by Boehringer Ingelheim, investigating a new therapy in bronchiectasis”
UNEEG
“CRF-UCC recruited the first patient in Ireland onto the UNEEG medical device study, which is the first Wireless Ultra Long-Term EEG recorder for Epilepsy, marking a significant advancement in epilepsy treatment.”
